Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth D Kirkpatrick

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Ebiomedicine|March 13, 2019
Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection modelUsha K Nivarthi, Huy A Tu, Matthew J Delacruz, et al.
The Journal of Infectious Diseases|February 2, 2018
Histo-Blood Group Antigen Phenotype Determines Susceptibility to Genotype-Specific Rotavirus Infections and Impacts Measures of Rotavirus Vaccine EfficacyBenjamin Lee, Dorothy M Dickson, Allan C deCamp, et al.
The American Journal of Tropical Medicine and Hygiene|May 13, 2020
Immunogenicity and Safety of a Tetravalent Recombinant Subunit Dengue Vaccine in Adults Previously Vaccinated with a Live Attenuated Tetravalent Dengue Vaccine: Results of a Phase-I Randomized Clinical TrialAnna P Durbin, Kristen K Pierce, Beth D Kirkpatrick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2016
Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El TorWilbur H Chen, Mitchell B Cohen, Beth D Kirkpatrick, et al.
The Lancet. Infectious Diseases|September 30, 2023
Safety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trialMary-Claire R Walsh, Mohammed Shafiul Alam, Kristen K Pierce, et al.
The Journal of Infectious Diseases|March 12, 2020
Maternal Secretor Status Affects Oral Rotavirus Vaccine Response in Breastfed Infants in BangladeshFrank B Williams, Abdul Kader, E Ross Colgate, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 11, 2013
Lack of homologous protection against Campylobacter jejuni CG8421 in a human challenge modelBeth D Kirkpatrick, Caroline E Lyon, Chad K Porter, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Kinetics and Isotype Assessment of Antibodies Targeting the Spike Protein Receptor Binding Domain of SARS-CoV-2 In COVID-19 Patients as a function of Age and Biological SexNancy R Graham, Annalis N Whitaker, Camilla A Strother, et al.
Vaccine|August 16, 2021
The fecal microbiome and rotavirus vaccine immunogenicity in rural Zimbabwean infantsRuairi C Robertson, James A Church, Thaddeus J Edens, et al.
Clinical Trials (London, England)|October 28, 2021
A site assessment tool for inpatient controlled human infection models for enteric disease pathogensChad K Porter, Katherine J Detizio, Nicole Maier, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Ebiomedicine|March 13, 2019
Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection modelUsha K Nivarthi, Huy A Tu, Matthew J Delacruz, et al.
The Journal of Infectious Diseases|February 2, 2018
Histo-Blood Group Antigen Phenotype Determines Susceptibility to Genotype-Specific Rotavirus Infections and Impacts Measures of Rotavirus Vaccine EfficacyBenjamin Lee, Dorothy M Dickson, Allan C deCamp, et al.
The American Journal of Tropical Medicine and Hygiene|May 13, 2020
Immunogenicity and Safety of a Tetravalent Recombinant Subunit Dengue Vaccine in Adults Previously Vaccinated with a Live Attenuated Tetravalent Dengue Vaccine: Results of a Phase-I Randomized Clinical TrialAnna P Durbin, Kristen K Pierce, Beth D Kirkpatrick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2016
Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El TorWilbur H Chen, Mitchell B Cohen, Beth D Kirkpatrick, et al.
The Lancet. Infectious Diseases|September 30, 2023
Safety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trialMary-Claire R Walsh, Mohammed Shafiul Alam, Kristen K Pierce, et al.
The Journal of Infectious Diseases|March 12, 2020
Maternal Secretor Status Affects Oral Rotavirus Vaccine Response in Breastfed Infants in BangladeshFrank B Williams, Abdul Kader, E Ross Colgate, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 11, 2013
Lack of homologous protection against Campylobacter jejuni CG8421 in a human challenge modelBeth D Kirkpatrick, Caroline E Lyon, Chad K Porter, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Kinetics and Isotype Assessment of Antibodies Targeting the Spike Protein Receptor Binding Domain of SARS-CoV-2 In COVID-19 Patients as a function of Age and Biological SexNancy R Graham, Annalis N Whitaker, Camilla A Strother, et al.
Vaccine|August 16, 2021
The fecal microbiome and rotavirus vaccine immunogenicity in rural Zimbabwean infantsRuairi C Robertson, James A Church, Thaddeus J Edens, et al.
Clinical Trials (London, England)|October 28, 2021
A site assessment tool for inpatient controlled human infection models for enteric disease pathogensChad K Porter, Katherine J Detizio, Nicole Maier, et al.
Pageof 12